Categories
Pages
-

SmartMedCN

Kategorie: ‘Government News’

Ten drug traceability standards are implemented

March 12th, 2020 | by

Recently, the NMPA issued the “Basic Dataset of Drug Traceability for Marketing Authorization Holders and Manufacturers,” “Basic Dataset of Drug Traceability for Pharmaceutical Companies,” “Basic Dataset of Drug Traceability for Medical Organizations,” “Basic Technical Requirements for Drug Traceability Data Exchange,” and “Basic Dataset of Drug Traceability for Consumer Inquiry.” Up to now, ten drug traceability standards that were issued by the NMPA have been implemented.

 

10个药品追溯标准发布实施,实现来源可查,去向可追

来源:制药网  2020.03.12

近日,国家药监局印发《药品上市许可持有人和生产企业追溯基本数据集》,《药品经营企业追溯基本数据集》,《药品使用单位追溯基本数据集》,《药品追溯数据交换基本技术要求》,《药品追溯消费者查询基本数据集》。截止目前,国家药监局组织编制的10个药品追溯标准规范现已全部发布实施。

The “One Invoice Policy” will be implemented

March 9th, 2020 | by

On March 5th, the State Council issued a document on reforming the medical and health care system. The document indicates that a regional and a national allied procurement system should be implemented to realize an orderly drug supply system with reasonable prices and competition; medical insurance agencies should deal with the settlement payment directly with manufacturers or pharmaceutical companies. Besides, provincial centralized procurement platforms that are based on medical insurance payment should be established, which combines bidding, procurement, trading, settlement, and supervision.

 

国务院:推行一票制 经销商结款方式要变了

来源:医药网  2020.03.09

3月5日,国务院官网发布医疗保障制度改革文件。文件提出,将推进构建区域型、全国性联盟采购机制,形成竞争充分、价格合理、规范有序的供应保障体系;推进由医保经办机构直接与药品生产或流通企业结算货款;应以医保支付为基础,建立招标、采购、交易、结算、监督一体化的省级招标采购平台。

Deepening the reform of the medical and health care system

March 6th, 2020 | by

On February 25th, the State Council issued the “Opinions on Deepening the Reform of the Medical and Health Care System.” The “Opinion” stipulates that medical institutions should improve the management of drug reimbursement lists, medical service protocols, and medicare settlement or increase the efficiency of medicare payment. Besides, the use of medical insurance funds should be strictly supervised, and insurance fraud will be dealt with according to legislation. In addition, the reform of centralized drug procurement should be deepened, and a pricing system that depends on the market should be established. Moreover, medical institutions should improve their service capacity and standardize new medical services, such as consulting over the internet.

关于深化医疗保障制度改革的意见

来源:医药网  2020.03.06

2月25日,国务院发布《关于深化医疗保障制度改革的意见》。《意见》要求,应完善医保目录、协议、结算管理,提升医保支付效率;完善医保基金监管,依法追究欺诈骗保行为;深化药品集中带量采购制度改革,并建立以市场为主导的药品价格形成机制;增强医疗服务能力,规范“互联网+医疗”等新服务模式发展。

 

 

Price management in medical institutions

January 6th, 2020 | by

On January 2nd, the National Health Commission issued the “Standard of Price Management in Medical Institutions,” which will come into effect as the date of promulgation. The “Standard” indicates that medical institutions should establish a price management system that is consisted of several departments. Besides, the “Standard” stipulates that medical institutions should make several staffs supervise the medical costs and adjust unreasonable charges. Besides, medical institutions should establish a system that can analyze and manage the medical service cost and make the costs of common medical services public.

 

国家卫健委:医疗机构内部价格行为管理规定

来源:医药网  2020.01.06

1月2日,国家卫健委发布《医疗机构内部价格行为管理规定》,并将自发布之日起施行。《规定》提出,各医疗机构应到建立由多部门组成的价格管理体系。《规定》要求,医疗机构应配备一定数量医疗服务价格工作人员,用于定期检查患者花费,纠正医院不规范收费;各医疗机构应建立医疗服务成本测算和成本控制管理制度,同时公示常用医疗服务项目的价格。

Hospital pharmacies and pharmacy chains cooperate

December 27th, 2019 | by

Recently, the Medical Product Administration of Guizhou province issued the “Notification on Improving Pharmacy Chains Management in Guizhou Province.” The “Notification” indicated that pharmacy chains are encouraged to provide pharmaceutical services jointly with hospital pharmacies according to their own supply practice. Besides, online prescribing and pharmaceutical services should be promoted as well.

医院药房要与药店打通了

来源:新浪医药新闻  2019.12.27

近日,贵州省药监局发布了《关于进一步规范全省药品零售企业管理工作的通知》(以下简称《通知》)。《通知》提出,药品零售企业在不改变药品经营方式的前提下,鼓励为社区医疗机构提供药房药事服务;积极推进“互联网+远程药学服务”进行远程审方。[:]

97 negotiations targeted drugs will be published on the internet (National Negotiation)

December 18th, 2019 | by

On December 16th, the NHSA and the National Health Commission jointly issued the “Notification on Ensuring the Usage and Supply of Drugs that are Targeted in the National Negotiation.” The “Notification” stipulated that provincial healthcare security administrations should publish the 97 negotiations targeted drugs on their centralized procurement platform and their new reimbursement drug lists. Besides, healthcare departments should regulate the usage and supply of these drugs and instruct medical institutions to reserve and use them properly according to functions, clinical requirements, and healing effects.

两部门发文:97个国家谈判药品按时直接挂网

来源:医药网  2019.12.18

1216日,国家医保局、国家卫健委联合发布《关于做好2019年国家医保谈判药品落地工作的通知》。《通知》要求,各省级医保部门应在规定时限内将97个谈判药品在省级药品集中采购平台上直接挂网,并保证新版目录及时落地。此外,各地医保和卫生部门应对谈判药品的配备及使用等方面提出具体要求,并指导各定点医疗机构根据功能定位、临床需求、和诊疗能力等即时配备、合理使用。

A national drug use supervision platform is launched

December 11th, 2019 | by

The National Health Commission announced that a national drug use supervision platform is launched, which can provide data to support healthcare administrations to supervise and analyse the drug use. 8840 medical institutions have registered on the platform.

国家药品使用监测平台上线运行 8000多家医院已登陆

来源:医药网 2019.12.11

国家卫健委统计信息中心今日发布消息,国家药品使用监测平台正式上线运行。目前,已有8840家医疗卫生机构完成系统登录。卫健委表示,“国家药品使用监测平台”将为各级卫生健康药政管理部门开展药品配备使用情况监测分析提供数据支撑。

Supervising the drug price and investigating the cost price

December 9th, 2019 | by

On December 6th, the National Medical Insurance Bureau issued the “Opinions on Supervising the Drug Price.” The “Opinion” indicated that a pricing system that depends on the market should be encouraged, and the centralised procurement with defined quantities, of which the drug price depends on the quantities and the bidding process combines with the procurement, should be further implemented. The “Opinion” also stipulated that a pre-warning system of abnormal drug price movements and an investigation system of the cost price of drugs should be established as well.

国家医保局发布文件:监管药品价格 调查成本

来源:医药网 2019.12.09

12月6日,国家医保局发布《关于做好当前药品价格管理工作的意见》(以下简称《意见》)。《意见》指出,坚持市场调节药品价格的总体方向;坚持“带量采购、量价挂钩、招采合一”的方针。《意见》要求,应建立价格供应异常变动监测预警机制,并完善药品价格成本调查工作机制。

 

Establishing a nationwide unified procurement platform of drugs

December 2nd, 2019 | by

On November 29th, the National Health Commission issued the “Notification on Measures of Deepening the Reform of the Medical and Healthcare System depending on the Centralised Procurement and Use of Drugs.” The “Notification” emphasised that a nationwide unified procurement platform based on provincial centralised procurement platforms should be established, in which the drug codes and procurement standards should be unified so that the drug price can be linked together nationwide. In addition, corporate groups, integrated healthcare organisations, private medical institutions, and pharmacies are encouraged to implement centralised procurement to develop a pricing system that depends on the market. The “Notification” also stipulated that the medical insurance administrative agencies instead of hospitals should pay for the drugs to manufacturers and distributors directly.

医药行业变革:建设全国采购平台 全国价格联动

来源:医药网 2019.12.02

11月29日,国家卫健委体制改革司发布《国务院深化医药卫生改革领导小组印发关于以药品集中采购和使用为突破口进一步深化医药卫生体制改革若干政策措施的通知》。《通知》强调,应依托省级集中采购平台构建全国公共采购市场,统一编码、标准和功能规范,推进价格等相关信息互联互通,促进全国价格联动;鼓励探索集团采购、医联体采购等方式形成合理价格,鼓励非公立医疗机构、社会药店等积极参与,共同推动形成以市场为主导的药品价格形成机制;《通知》还要求,应由医保经办机构直接与生产或流通企业结算药品货款。

Online drug selling is being supervised

November 23rd, 2019 | by

Recently, the National Development and Reform Commission and Ministry of Commerce jointly issued the “Negative List of Market access (2019 version),” which proposed that drug production and trading companies are not allowed to sell prescription drugs directly to the public through mail or internet trade.

网络售药行为进一步规范,邮寄处方药全面叫停

来源:制药网 2019.11.23

日前,国家发改委、商务部联合发布《市场准入负面清单(2019年版)》。其中明确提出:“药品生产、经营企业不得违反规定采用邮寄、互联网交易等方式直接向公众销售处方药。”